Literature DB >> 19115972

Should HLA-B*5701 screening be performed in every ethnic group before starting abacavir?

Wan Beom Park1, Pyoeng Gyun Choe, Kyoung-Ho Song, Shinwon Lee, Hee-Chang Jang, Jae Hyun Jeon, Sang-Won Park, Myoung Hee Park, Myoung-don Oh, Kang Won Choe.   

Abstract

Human leukocyte antigen allele (HLA)-B*5701 is associated with abacavir hypersensitivity. However, the carriage rate of HLA-B*5701 has rarely been studied in Asians. In 534 Korean patients with human immunodeficiency virus infection, HLA-B*5701 status was determined by polymerase chain reaction with HLA-B*5701-specific primers. No patients had the HLA-B*5701 allele (95% confidence interval, 0%-0.7%). This explains the paucity of immunologically confirmed cases of abacavir hypersensitivity in Koreans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19115972     DOI: 10.1086/595890

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  11 in total

Review 1.  Epidemiology and risk factors for drug allergy.

Authors:  Bernard Y-H Thong; Teck-Choon Tan
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

Review 2.  Hypersensitivity reactions to HIV therapy.

Authors:  Mas Chaponda; Munir Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

Review 3.  Role of pharmacogenetics in public health and clinical health care: a SWOT analysis.

Authors:  Ritika Kapoor; Wei Chuen Tan-Koi; Yik-Ying Teo
Journal:  Eur J Hum Genet       Date:  2016-08-31       Impact factor: 4.246

4.  Prevalence of human leukocyte antigen-B*5701 among HIV-infected children in Thailand and Cambodia: implications for abacavir use.

Authors:  Thanyawee Puthanakit; Torsak Bunupuradah; Pope Kosalaraksa; Ung Vibol; Rawiwan Hansudewechakul; Sasiwimol Ubolyam; Tulathip Suwanlerk; Suparat Kanjanavanit; Chaiwat Ngampiyaskul; Jurai Wongsawat; Wicharn Luesomboon; Saphonn Vonthanak; Jintanat Ananworanich; Kiat Ruxrungtham
Journal:  Pediatr Infect Dis J       Date:  2013-03       Impact factor: 2.129

Review 5.  Drug-Induced Skin Adverse Reactions: The Role of Pharmacogenomics in Their Prevention.

Authors:  Kalliopi Gerogianni; Aspasia Tsezou; Konstantinos Dimas
Journal:  Mol Diagn Ther       Date:  2018-06       Impact factor: 4.476

6.  Safety analysis of Ziagen® (abacavir sulfate) in postmarketing surveillance in Japan.

Authors:  Tomoko Kurita; Tomomi Kitaichi; Takako Nagao; Toshiyuki Miura; Yoshifumi Kitazono
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-03-03       Impact factor: 2.890

7.  Low prevalence of human leukocyte antigen-B*5701 in HIV-1-infected Chinese subjects: a prospective epidemiological investigation.

Authors:  Hongwei Zhang; Tong Zhang; Hongxin Zhao; Ning Han; Haiwei Zhou; Yun He; Qingxia Zhao; Hong Li; Huiqin Li; Mi Zhang; Jianjian Li; Yongtao Sun; Ke Zhao; Qing Liu; Zhiying Liu; Zhen Li; Wei Xia; Yun Lan; Haolan Hu; Weiping Cai; Hao Wu
Journal:  AIDS Res Ther       Date:  2015-08-19       Impact factor: 2.250

Review 8.  Pathogenesis and diagnosis of delayed-type drug hypersensitivity reactions, from bedside to bench and back.

Authors:  Rik Schrijvers; Liesbeth Gilissen; Anca Mirela Chiriac; Pascal Demoly
Journal:  Clin Transl Allergy       Date:  2015-09-03       Impact factor: 5.871

9.  The use of pharmacogenetics in clinical practice for the treatment of individuals with HIV infection in Thailand.

Authors:  Asalaysa Bushyakanist; Apichaya Puangpetch; Chonlaphat Sukasem; Sasisopin Kiertiburanakul
Journal:  Pharmgenomics Pers Med       Date:  2015-11-05

10.  Safety and Efficacy of Ziagen (Abacavir Sulfate) in HIV-Infected Korean Patients.

Authors:  Heawon Ann; Ki Hyon Kim; Hyun Young Choi; Hyun Ha Chang; Sang Hoon Han; Kye Hyung Kim; Jin Soo Lee; Yeon Sook Kim; Kyung Hwa Park; Young Keun Kim; Jang Wook Sohn; Na Ra Yun; Chang Seop Lee; Young Wha Choi; Yil Seob Lee; Shin Woo Kim
Journal:  Infect Chemother       Date:  2017-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.